Rifampin Capsule
Product Images NDC 68180-658

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rifampin (NDC 68180-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rifampin (3fc5afd7 A046 4b77 9ebe 87cde4f1516e 01)

FDA Label Image

Rifampin Capsules Usp150 mg 30s Pack (3fc5afd7 A046 4b77 9ebe 87cde4f1516e 02)

This is a medication with NDC code 68180-658-06, containing 150mg of rifampin USP per capsule. The drug comes in a container with child-resistant closure and must be stored in a dry place, protected from excessive heat and light. The prescribing information must be consulted for proper dosage and administration. The drug is manufactured by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, and the package includes 30 capsules, to be dispensed by a pharmacist.*

FDA Label Image

Rifampin Capsules Usp300 mg 30s Pack (3fc5afd7 A046 4b77 9ebe 87cde4f1516e 03)

This is a drug with the National Drug Code (NDC) 68180-659-06, and trade name Rifampin. It comes in Capsules form with each capsule having 300 mg of Rifampin. The drug is to be kept out of reach of children and dispensed with a child-resistant cap into a light-resistant and tight container. The prescribing information should be followed for the drug's dosage and administration. The drug is manufactured by Lupin Pharmaceuticals, Inc. and should be kept tightly closed, in a dry place at a temperature of 25°C (77°F), with excursions to 15-30°C (59-86°F) permitted.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.